1 year ago
Pharma Medica Research Inc. (PMRI) is extremely pleased to announce that the US FDA has concluded a 5-day inspection of the bioanalytical unit in Mississauga, Ontario, Canada with no 483 Form issued. Two Inspectors from the Study Integrity & Surveillance Department performed an unannounced, in-depth review of data generated from 10 studies from 2015 until present specifically from a bioanalytical perspective. The Inspectors indicated that they were very impressed with our staff and indicated that PMRI does “good work” and provided all the records requested in a timely manner.
1 year and 2 months ago
Pharma Medica Research Inc. (PMRI) is extremely pleased to announce that the FDA has concluded a 4-day intense inspection of our clinical unit in St. Charles, Missouri, USA with no 483 Form issued. The Inspector performed an extensive review of documentation from two recent studies in addition to SOPs and training & equipment records. The Inspector indicated that the records are in very good order, there are strong documentation practices and summarized the audit as being very successful!
2 years and 6 months ago
We are pleased to announce the launch of our new website. Since many visitors use a mobile phone as well as a desktop computer to visit our site; we have redesigned the website so that the view adapts from desktop to tablet to mobile phone. We hope you like it, and feedback is always welcome.
5 years and 10 months ago
Missouri governor Jay Nixon joined the leadership of PMRI, as well as local government and economic development officials, in cutting the ribbon on the company's new research facility in St. Charles, Missouri.
8 years and 2 months ago
We are excited to announce that on July 26, 2010 PMRI received ANVISA certification for its clinical, bioanalytical, & statistical services.
As part of the certification process, ANVISA assessors conducted a thorough and rigorous review of the PMRI quality systems; training programs; clinical, analytical, & statistical procedures; as well as detailed inspections of our clinical and bioanalytical facilities.
The outcome was successful.
The inspectors indicated that they were impressed by the systems and processes that PMRI has in place to help ensure compliance with GCP/GLP and the professionalism of the team.
PMRI has now been successfully GCP/GLP inspected by the FDA/EMEA/ANVISA. We were also the first CRO to be GLP certified by the Standards Council of Canada. We are very proud of the staff whose scientific expertise and uncompromising commitment to quality continue to contribute to these achievements.
8 years and 6 months ago
The online list of bioanalytical methods has been completely redesigned. The intelligent search feature makes it faster and easier to find the information you are looking for.
You can still find the method list by visiting Bioanalytical Services.
10 years and 9 months ago
Pharma Medica Research Inc recently completed a voluntary GLP inspection and study audit by the Standards Council of Canada (SCC). We are the first CRO to be officially recognized as GLP compliant for bioanalysis of clinical trial and pre-clinical study samples. The SCC is a Government of Canada institution mandated to facilitate the development, use, and accreditation of national and international standards.
In addition to our previous successful FDA and EMEA inspections, accreditation by the SCC further demonstrates our commitment to quality. PMRI maintains its leadership position as a quality service provider through extensive training, qualified staff, and detailed SOPs. We are also continuously monitoring the expectations of global regulatory bodies to ensure that we remain a leader in the field.
10 years ago
We are very excited to launch our new corporate and volunteer website. This update should provide easier access to information about our services for both clients and study volunteers.
Take a look around and do not hesitate to let us know what you think about our makeover!
10 years and 2 months ago
We would like to update you about a recent enhancement to our clinical capabilities. We are now able to offer patient studies in various psychiatric populations in-house.
Collaborating with local specialists we have access to a large network of patient groups from which we can recruit subjects. Utilizing our clinic facilities and well established BA/BE procedures we are able to offer the quality and timelines that you have come to expect - all at reasonable costs.
If you have any specific questions or would like pricing and clinic availability, please let us know.
10 years and 3 months ago
Pharma Medica Research Inc has officially announced the grand opening of our new 115,000 square foot clinical research facility. This 360-bed state-of-the-art building divided into 6 fully self-sufficient units will now be the primary location from which we will run our clinical trials.
Custom designed by the front-line managers who work in the clinic, we have successfully built a facility optimized for the workflow in clinical research. Combined with our professional staff and well developed procedures this facility allows us to offer you more flexible scheduling, efficient timelines and higher quality service.
Located in eastern Toronto, with easy access to public transit, semi-private bunk rooms and unparalleled recreational and hospitality services - PMRI makes every effort to make the study participants feel like they are part of the family.
We would be happy to give you a tour of our facility!